Submitted by Anonymous (not verified) on 22 April 2026 - 15:28
Human medicines European public assessment report (EPAR): Volibris, ambrisentan, Date of authorisation: 21/04/2008, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Volibris, ambrisentan, Date of authorisation: 21/04/2008, Revision: 27, Status: Authorised